ALT FY 2008 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$319M

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+124.7% YoY

Gross Profit

$33M100.0% margin

Operating Income

-$35M-107.1% margin

Net Income

-$36M-110.6% margin

EPS (Diluted)

$-476.15

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$56M

Total Liabilities

$37M

Stockholders' Equity

$19M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$15M	+124.7%
Gross Profit	$33M	$15M	+124.7%
Operating Income	-$35M	-$17M	-113.6%
Net Income	-$36M	-$14M	-168.0%